Vivo Biotech's consolidated quarterly numbers show a decline in net sales by 4.95% to Rs 12.21 crore and net profit by 37.92% to Rs 0.82 crore in December 2024 compared to the same period last year. Vivo Biotech's EPS decreased to Rs 0.55 from Rs 0.89 in December 2023. Vivo Biotech shares closed at 46.83 on January 10, 2025, with 24.45% returns over the last 6 months.

Top ELSS Mutual Funds With Best SIP Returns in 3 Years: Equity Linked Saving Scheme (ELSS) Mutual Funds are also known as tax saver mutual funds that provide tax benefits to the taxpayers following the old tax regime. Taxpayers can claim up to Rs 1.50 lakh in tax benefits in a financial year under Section 80C of the Income Tax Act, 1961.

Laxmi Dental, a name in the dental products industry, opened its IPO for subscription today, January 13, and will close on January 15. If you are considering applying, here are the details of this IPO and what it means for you. Laxmi Dental IPO, a mainboard offering has set his price band between the range of Rs 407 to Rs 428 per share.

The Nifty 50 index has fallen 11% from its peak, signaling a sharp correction across Indian equities. Despite the decline, Kotak Institutional Equities remains unconvinced about market prospects, warning that there is no real value to be found even after the pullback, citing stretched valuations, limited earnings growth potential, and unfavorable global macroeconomic conditions.

Reported Consolidated quarterly numbers for Equinox India Developments are: Net Sales at Rs 278.50 crore in December 2024 up 176.98% from Rs. 100.55 crore in December 2023. Quarterly Net Profit at Rs. 22.17 crore in December 2024 up 157.36% from Rs. 38.65 crore in December 2023. EBITDA stands at Rs. 34.08 crore in December 2024 up 256.33% from Rs. 21.80 crore in December 2023.

India's legacy international airline, Air India, is confident that its upcoming first-class product, set to debut with its new wide-body fleet in the next few years, will offer high-net-worth individuals an alternative to private jets on long-haul routes like Delhi to London, offering high-net-worth individuals a non-stop flying experience with its Airbus A350-1000 and Boeing 777X aircraft.

The Indian rupee hit a lifetime low of 86.31 against the US dollar on Monday, marking its second consecutive session of losses. Several domestic and global factors have driven this sharp depreciation. Here are the key reasons: Higher US bond yields, with the 10-year yield at 4.71 percent, have also added pressure on emerging market currencies, including the rupee.

Shares of Rail Vikas Nigam Ltd., the state-run railway and construction company are down another 7% on Monday, in-line with the continuing pain in the midcap and smallcap space. This is the third straight day of losses for the railway PSU. With Monday's fall, RVNL shares are now down 45% from their peak of ₹647, which they had hit in August last year.

Rahul Chadha, CIO of Shikhara Investment Management, believes the next 3-6 months offer a buying opportunity in the Indian market, particularly in large caps, and later in mid and small caps after a further 15-20% correction, citing a strong structural story and 17-18% cheaper valuations in dollar terms.

Nifty 50 index has corrected 12% from its record high, with nearly two-thirds of its constituents declining over 10%. Four stocks, including 📌IndusInd Bank, 📌Bajaj Auto, 📌Hero MotoCorp, and 📌Asian Paints, have fallen over 30% from September 27 levels. NTPC and Coal India are among other top losers, with potential upside expected.

TCS's Q3FY25 revenue and profits met estimates, with revenue growing 5.6% YoY, driven by strong performance in Latin America, UK, and India. PAT stood at INR 123,800 Mn, up 12% YoY, with a PAT margin of 19.5%. The company's robust deal pipeline and improving macro-economic conditions are expected to drive substantial revenue growth, with a target price of INR 4,631 and an "ACCUMULATE" rating.

Shares of Piramal Pharma saw strong buying interest on Monday, January 13, defying weak market sentiment. While the equity benchmark Sensex crashed over a per cent, Piramal Pharma share price surged over 9 per cent after three sessions of losses. Piramal Pharma share price opened at ₹217.85 against its previous close of ₹221.65 and jumped 9.45 per cent to the level of ₹242.60.

Apple surpasses Rs 1 lakh crore mark in iPhone exports from India, reaching a record $12.8 billion, a 42% year-on-year increase, driven by a rise in local value addition and domestic production. Apple's local value addition has grown to 15-20%, and domestic production totaled $17.5 billion, with the company projected to achieve $30 billion in annual production within a few years.

Kalyan Jewellers India's shares extended their bearish trend for the seventh consecutive trading session, falling 7% to a 20-week low of ₹584, attributed to profit booking after a 651% rally between March 2023 and December 2024. Despite this, the company reported strong Q3 FY25 business updates and plans to launch new showrooms.

HCL Tech Q3 Results Live Updates: HCL Technologies will post its results for the October to December 2024 quarter after market hours on January 13. A key factor to watch is if the IT giant will revise its FY25 revenue guidance. Analysts polled by CNBC-TV18 expect the firm’s revenue to rise 4% and profit to go up 9% on a sequential basis. Ahead of Q3 results, HLC Tech shares traded lower.